Maspin polymorphism associated with apoptosis susceptibility and in vivo tumorigenesis

International Journal of Molecular Medicine

Volumn 22, Issue 3, 2008, Pages 333-338

  Jang, Hye Lim ^a   Nam, Eunsook ^a   Lee, Kon Ho ^b   Yeom, Seonyong ^a   Son, Hee Jung ^a   Park, Chaehwa ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Gyeongsang National University   (South Korea)

Author keywords

Apoptosis; Maspin; Polymorphism; Tumorigenesis

Indexed keywords

CYTOSINE; MASPIN; PROLINE; SERINE; THREONINE; SERINE PROTEINASE INHIBITOR; SERPIN B5; SERPIN-B5;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; LUNG CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN POLYMORPHISM; PROTEIN TERTIARY STRUCTURE; STOMACH CANCER; STOMACH CARCINOGENESIS; AMINO ACID SEQUENCE; ANIMAL; CELL TRANSFORMATION; CHEMICAL STRUCTURE; CHEMISTRY; DISEASE PREDISPOSITION; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; GENETICS; METABOLISM; MUTATION; NUCLEOTIDE SEQUENCE; NUDE MOUSE; TUMOR CELL LINE;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; BASE SEQUENCE; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DISEASE SUSCEPTIBILITY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; MICE; MICE, NUDE; MODELS, MOLECULAR; MUTATION; POLYMORPHISM, GENETIC; PROTEIN STRUCTURE, TERTIARY; SERPINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 53049094830     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm_00000027     Document Type: Article

References (18)

1. Schneider SS, Schick C, Fish KE, Miller E, Pena JC, Treter SD, Hui SM and Silverman GA: A serine proteinase inhibitor locus at 18q21.3 contains a tandem duplication of the human squamous cell carcinoma antigen gene. Proc Natl Acad Sci USA 92: 3147-3151, 1995.
2. Sheng S, Pemberton PA and Sager R: Production, purification, and characterization of recombinant maspin proteins. J Biol Chem 269: 30988-30993, 1994.
3. McGowen R, Biliran H Jr, Sager R and Sheng S: The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin. Cancer Res 60: 4771-4778, 2000.
4. Pemberton PA, Wong DT, Gibson HL, Kiefer MC, Fitzpatrick PA, Sager R and Barr PJ: The tumor suppressor maspin does not undergo the stressed to relaxed transition or inhibit trypsin-like serine proteases. Evidence that maspin is not a protease inhibitory serpin. J Biol Chem 270: 15832-15837, 1995.
5. Zou Z, Anisowicz A, Hendrix MJ, Thor A, Neveu M, Sheng S, Rafidi K, Seftor E and Sager R: Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 263: 526-529,1994.
6. Hendrix MJ: De-mystifying the mechanism(s) of maspin. Nat Med 6: 374-376, 2000.
7. Sheng S, Carey J, Seftor EA, Dias L, Hendrix MJ and Sager R: Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proc Natl Acad Sci USA 93: 11669-11674, 1996.
8. Machtens S, Serth J, Bokemeyer C, Bathke W, Minssen A, Kollmannsberger C, Hartmann J, Knuchel R, Kondo M, Jonas U and Kuczyk M: Expression of the p53 and Maspin protein in primary prostate cancer: correlation with clinical features. Int J Cancer 95: 337-342, 2001.
9. Kim S, Han J, Kim J and Park C: Maspin expression is trans-activated by p63 and is critical for the modulation of lung cancer progression. Cancer Res 64: 6900-6905, 2004.
10. Maass N, Hojo T, Ueding M, Luttges J, Kloppel G, Jonat W and Nagasaki K: Expression of the tumor suppressor gene Maspin in human pancreatic cancers. Clin Cancer Res 7: 812-817, 2001.
11. Sood AK, Fletcher MS, Gruman LM, Coffin JE, Jabbari S, Khalkhali-Ellis Z, Arbour N, Seftor EA and Hendrix MJ: The paradoxical expression of maspin in ovarian carcinoma. Clin Cancer Res 8: 2924-2932, 2002.
12. Akiyama Y, Maesawa C, Ogasawara S, Terashima M and Masuda T: Cell-type-specific repression of the maspin gene is disrupted frequently by demethylation at the promoter region in gastric intestinal metaplasia and cancer cells. Am J Pathol 163: 1911-1919,2003.
13. Umekita Y, Hiipakka RA and Liao S: Rat and human maspins: structures, metastatic suppressor activity and mutation in prostate cancer cells. Cancer Lett 113: 87-93, 1997.
14. Al-Ayyoubi M, Gettins PG and Volz K: Crystal structure of human maspin, a serpin with antitumor properties: reactive center loop of maspin is exposed but constrained. J Biol Chem 279: 55540-55544, 2004.
15. Law RH, Irving JA, Buckle AM, Ruzyla K, Buzza M, Bashtannyk-Puhalovich TA, Beddoe TC, Nguyen K, Worrall DM, Bottomley SP, Bird PI, Rossjohn J and Whisstock JC: The high resolution crystal structure of the human tumor suppressor maspin reveals a novel conformational switch in the G-helix. J Biol Chem 280: 22356-22364, 2005.
16. Collaborative Computational Project, Number 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr 50: 760-763, 1994,
17. DeLano WL: The PyMOL Molecular Graphics System 2002 on world wide web, http://www.pymol.org.
18. Liu J, Yin S, Reddy N, Spencer C and Sheng S: Bax mediates the apoptosis-sensitizing effect of maspin. Cancer Res 64: 1703-1711, 2004.